A Network Investigation on Idiopathic Hypogonadotropic Hypogonadism in China

被引:1
作者
Zhao, Weiwei [1 ]
Ye, Hongying [1 ]
Zhao, Xiaolong [1 ]
Zhang, Zhaoyun [1 ]
Sun, Shouyue [2 ]
Jiang, Yiran [2 ]
He, Min [1 ]
Xu, Cheng [1 ]
Hu, Renming [1 ]
Li, Yiming [1 ]
机构
[1] Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200040, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Endocrine & Metab Dis, Dept Endocrinol & Metab,Ruijin Hosp, Shanghai 200025, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
MATURATION; INTERNET; HORMONE;
D O I
10.1155/2013/591012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Idiopathic hypogonadotropic hypogonadism (IHH) is a rare condition in which puberty does not take place naturally. We aimed to develop and follow an internet-based cohort and to improve our understanding of the disease. We established an internet-based questionnaire survey. A total of 74 male IHH patients were recruited from the Chinese largest IHH network social group. The clinical symptoms before treatment mainly included small testis, underdeveloped secondary sexual characteristics, and sexual dysfunction. After treatment, the penis length, testicular volume, external genital organ development, pubic hair, beard, laryngeal prominence, erection, and spermatorrhea were improved significantly (P < 0.001). 18.9% of the patients completed fertility; however, more than half of the patients still complained of poor happiness and low physical strength. In addition, improvements in penis and pubic hair development, testosterone normalization and the physical strength in IHH patients who received gonadotropin and androgen replacement therapy were better than in those who received single gonadotropin therapy (P < 0.05 for all). In conclusion, disease-specific network investigation can be used as an alternative method of medical research for rare diseases. The results of our cross-sectional study showed the effectiveness of hormone replacement therapy for IHH and implied that gonadotropin and androgen replacement therapy may be superior to gonadotropin treatment alone.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] The Clinical and Genetic Characteristics in Children with Idiopathic Hypogonadotropin Hypogonadism
    Zhou, Qiong
    Sheng, Wenbin
    Yang, Suhong
    Zou, Chaochun
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [22] Congenital hypogonadotropic hypogonadism/Kallmann syndrome is associated with statural gain in both men and women: a monocentric study
    Maione, Luigi
    Pala, Giovanna
    Bouvattier, Claire
    Trabado, Severine
    Papadakis, Georgios
    Chanson, Philippe
    Bouligand, Jerome
    Pitteloud, Nelly
    Dwyer, Andrew A.
    Maghnie, Mohamad
    Young, Jacques
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2020, 182 (02) : 185 - 194
  • [23] FSH and Sertoli Cell Biomarkers Accurately Distinguish Hypogonadotropic Hypogonadism From Self-limited Delayed Puberty
    Castro, Sebastian
    Brito, Lourdes Correa
    Bedecarras, Patricia
    Ballerini, Maria Gabriela
    Sanso, Gabriela
    Keselman, Ana
    Cassinelli, Hamilton
    Arcari, Andrea Josefina
    Alonso, Guillermo F.
    Chan, Yee-Ming
    He, Wen
    Ropelato, Maria Gabriela
    Bergada, Ignacio
    Cassorla, Fernando
    Rey, Rodolfo A.
    Grinspon, Romina P.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,
  • [24] Kisspeptin-54 Accurately Identifies Hypothalamic Gonadotropin-Releasing Hormone Neuronal Dysfunction in Men with Congenital Hypogonadotropic Hypogonadism
    Abbara, Ali
    Eng, Pei Chia
    Phylactou, Maria
    Clarke, Sophie A.
    Mills, Edouard
    Chia, Germaine
    Yang, Lisa
    Izzi-Engbeaya, Chioma
    Smith, Neil
    Jayasena, Channa N.
    Comninos, Alexander N.
    Anand-Ivell, Ravinder
    Rademaker, Jesse
    Xu, Cheng
    Quinton, Richard
    Pitteloud, Nelly
    Dhillo, Waljit S.
    NEUROENDOCRINOLOGY, 2021, 111 (12) : 1176 - 1186
  • [25] Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial
    Jones, T. Hugh
    Dobs, Adrian S.
    Randeva, Harpal
    Moore, William
    Parkin, Jacqueline M.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2023, 189 (03) : 297 - 308
  • [26] Case report: Novel SIN3A loss-of-function variant as causative for hypogonadotropic hypogonadism in Witteveen-Kolk syndrome
    Brito, Lourdes Correa
    Keselman, Ana
    Villegas, Florencia
    Scaglia, Paula
    Azcoiti, Maria Esnaola
    Castro, Sebastian
    Sanguineti, Nora
    Izquierdo, Agustin
    Maier, Marianela
    Bergada, Ignacio
    Arberas, Claudia
    Rey, Rodolfo A.
    Ropelato, Maria Gabriela
    FRONTIERS IN GENETICS, 2024, 15
  • [27] Gene Expression Changes Underlying Idiopathic Central Hypogonadism in Cryptorchidism with Defective Mini-Puberty
    Hadziselimovic, Faruk
    Gegenschatz-Schmid, Katharina
    Verkauskas, Gilvydas
    Docampo-Garcia, Maria J.
    Demougin, Philippe
    Bilius, Vytautas
    Malcius, Dalius
    Dasevicius, Darius
    Stadtler, Michael B.
    SEXUAL DEVELOPMENT, 2016, 10 (03) : 136 - 146
  • [28] Alterations of the FSH and LH receptor genes and evaluation of sperm ultrastructure in men with idiopathic hypergonadotropic hypogonadism
    Collodel, G.
    Cantara, S.
    Di Cairano, G.
    Moretti, E.
    Taglianetti, S.
    Pacini, Furio
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2013, 30 (09) : 1101 - 1108
  • [29] A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin
    Warne, David W.
    Decosterd, Genevieve
    Okada, Hiroshi
    Yano, Yumiko
    Koide, Nakako
    Howles, Colin M.
    FERTILITY AND STERILITY, 2009, 92 (02) : 594 - 604
  • [30] Additional mutation in PROKR2 and phenotypic differences in a Kallmann syndrome/normosmic congenital hypogonadotropic hypogonadism family carrying FGFR1 missense mutation
    Ichioka, Kentaro
    Yoshikawa, Takeshi
    Kimura, Hiroko
    Saito, Ryoichi
    BMJ CASE REPORTS, 2024, 17 (01)